Amyotrophic Lateral Sclerosis (ALS)

• Usnoflast Neuromuscular Investigation for Treatment Efficacy in ALS (UNITE-ALS) Pending
  2025-522580-15-00 4
• A PHASE II, SINGLE-CENTER, RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF THE COMBINED THERAPY OF EH-301 AND N- … Recruiting
  2024-519857-13-00 9 2025-11-25
• A clinical trial to learn about the effects of VHB937 in people with amyotrophic lateral sclerosis (ALS) Recruiting
  2024-512536-29-00 4 2025-02-28
• Phase IIB Study of PHENOGENE-1A (Cromolyn) as an Adjuvant Therapy in Mild to Moderate ALS Recruiting
  2025-520688-42-00 4 2026-01-27
• A clinical trial to learn how an investigational drug (MP-101) affects on the laboratory signs of the disease when given to Amyotrophic Late … Recruiting
  2023-507195-43-00 3 2024-07-01
• Safety and exploratory efficacy of AMT-162 for adults with SOD1 ALS Recruitment ended
  2024-517244-57-00 9 2025-03-03
• ALS phase II study of NX210c (SEALS) Recruitment ended
  2023-508895-13-00 4 2024-10-25
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of … Recruitment ended
  2023-507363-20-00 1 2024-07-12
• A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants Ended
  2024-518833-27-00 3 2025-01-10
• A Randomized, Placebo-Controlled, Double-Blind, Single Dose, Phase 1 Study to Explore the PK/PD Relationship of QRL-101 in People Living Wit … Ended
  2024-515021-29-00 3 2024-11-11
• A safety and efficacy study of ARGX-119 in adult patients with Amyotrophic Lateral Sclerosis (ALS) (reALiSe) Ended
  2024-511318-19-00 4 2024-10-23
• A study in healthy male adult participants to assess how much test medicine (SAR443820) is taken up, broken down and removed by the body whe … Ended
  2022-502534-23-00 9 2023-06-02
• A Phase 2a study to evaluate, safety, tolerability, pharmacodynamic markers, and pharmacokinetics of AP-101 in patients with amyotrophic lat … Ended
  2024-512343-23-00 4 2022-01-12
• A study to investigate the safety and efficacy of AMX0035 in patients with Amyotrophic Lateral Sclerosis Ended
  2023-508511-23-00 5 2021-12-02
• WALKALS : A pilot phase II study to evaluate the effect of salbutamol on walking capacity in ambulatory ALS patients. Expired
  2022-501624-14-00 4

Showing 1–15 of 15 trials